Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
N1VO34 | B3 | BRL | Delayed | |
NOVOBc | BATS Europe | DKK | Delayed | |
NVO | NYSE | USD | Real-time | |
0QIU | London | DKK | Real-time | |
NVON | Mexico | MXN | Delayed | |
NOVG | Dusseldorf | EUR | Delayed | |
NOVG | Xetra | EUR | Delayed | |
NOVG | Frankfurt | EUR | Delayed | |
NVONy | TradeGate | EUR | Delayed | |
NOVOb | Copenhagen | DKK | Real-time | |
NNO2 | Vienna | EUR | Real-time |
Novo Nordisk A/S reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was DKK 71,311 million compared to DKK 58,731 million a year ago. Net income was DKK 27,301 million compared to DKK 22,478 million a year ago. Basic earnings per share from continuing operations was DKK 6.13 compared to DKK 5.02 a year ago. Diluted earnings per share from continuing operations was DKK 6.12 compared to DKK 5 a year ago. For the nine months, sales was DKK 204,720 million compared to DKK 166,398 million a year ago. Net income was DKK 72,758 million compared to DKK 61,720 million a year ago. Basic earnings per share from continuing operations was DKK 16.33 compared to DKK 13.75 a year ago. Diluted earnings per share from continuing operations was DKK 16.29 compared to DKK 13.71 a year ago.
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Total Revenue | 71311 | 68060 | 65349 | 65863 |
Gross Profit | 60003 | 57786 | 55433 | 55849 |
Operating Income | 33822 | 31634 | 31846 | 28180 |
Net Income | 27301 | 20050 | 25407 | 21963 |
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Total Assets | 397441 | 369383 | 298921 | 314486 |
Total Liabilities | 276919 | 256861 | 200010 | 207925 |
Total Equity | 120522 | 112522 | 98911 | 106561 |
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 43850 | 50503 | 14314 | 9551 |
Cash From Investing Activities | -20904 | -20731 | 3956 | -14717 |
Cash From Financing Activities | -18401 | 16683 | -26382 | -10116 |
Net Change in Cash | 4197 | 46497 | -8068 | -15491 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review